Rapid Identification of the NAT2 Genotype in Tuberculosis Patients by Multicolor Melting Curve Analysis

References

• World Health Organization . Global tuberculosis report of 2015 ( 2015 ). http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1 .
   Google Scholar
• Boelsterli UA , LeeKK . Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress . J. Gastroenterol. Hepatol.29 ( 4 ), 678 – 687 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zabost A , BrzezinskaS , KozinskaMet al. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients . BioMed. Res. Int.2013 , 853602 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bolt HM , SelinskiS , DannappelD , BlaszkewiczM , GolkaK . Re-investigation of the concordance of human NAT2 phenotypes and genotypes . Arch. Toxicol.79 ( 4 ), 196 – 200 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hein DW . N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine . Expert Opin. Drug Metab. Toxicol.5 ( 4 ), 353 – 366 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Azuma J , OhnoM , KubotaRet al. NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy . Eur. J. Clin. Pharmacol.69 ( 5 ), 1091 – 1101 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Database of arylamine N-acetyltransferases . http://nat.mbg.duth.gr .
   Google Scholar
• Hein DW , DollMA . Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes . Pharmacogenomics13 ( 1 ), 31 – 41 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Selinski S , BlaszkewiczM , IckstadtK , HengstlerJG , GolkaK . Improvements in algorithms for phenotype inference: the NAT2 example . Curr. Drug Metab.15 ( 2 ), 233 – 249 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Doll MA , ZangY , MoellerT , HeinDW . Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes . J. Pharmacol. Exp. Ther.334 ( 2 ), 540 – 544 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hein DW , BoukouvalaS , GrantDM , MinchinRF , SimE . Changes in consensus arylamine N-acetyltransferase gene nomenclature . Pharmacogenet. Genomics18 ( 4 ), 367 – 368 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Vatsis KP , WeberWW , BellDAet al. Nomenclature for N-acetyltransferases . Pharmacogenetics5 ( 1 ), 1 – 17 ( 1995 ).
   PubMedGoogle Scholar
• Hein DW , GrantDM , SimE . Update on consensus arylamine N-acetyltransferase gene nomenclature . Pharmacogenetics10 ( 4 ), 291 – 292 ( 2000 ).
   PubMedGoogle Scholar
• Walraven JM , ZangY , TrentJO , HeinDW . Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2 . Curr. Drug Metab.9 ( 6 ), 471 – 486 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Evans DA , ManleyKA , McKV . Genetic control of isoniazid metabolism in man . Br. Med. J.2 ( 5197 ), 485 – 491 ( 1960 ).
   PubMed Web of Science ®Google Scholar
• Weber WW , HeinDW . N-acetylation pharmacogenetics . Pharmacol. Rev.37 ( 1 ), 25 – 79 ( 1985 ).
   PubMed Web of Science ®Google Scholar
• Cascorbi I , BrockmollerJ , MrozikiewiczPM , MullerA , RootsI . Arylamine N-acetyltransferase activity in man . Drug Metab. Rev.31 ( 2 ), 489 – 502 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Donald PR , SirgelFA , VenterAet al. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid . Clin. Infect. Dis.39 ( 10 ), 1425 – 1430 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Ohno M , YamaguchiI , YamamotoIet al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity . Int. J. Tuberc. Lung Dis.4 ( 3 ), 256 – 261 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Huang YS , ChernHD , SuWJet al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis . Hepatology35 ( 4 ), 883 – 889 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ng CS , HasnatA , Al MarufAet al. N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group . Eur. J. Clin. Pharmacol.70 ( 9 ), 1079 – 1086 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Verhagen LM , CoenenMJ , LopezDet al. Full-gene sequencing analysis of NAT2 and its relationship with isoniazid pharmacokinetics in Venezuelan children with tuberculosis . Pharmacogenomics15 ( 3 ), 285 – 296 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lin HJ , HanCY , LinBK , HardyS . Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene . Pharmacogenetics4 ( 3 ), 125 – 134 ( 1994 ).
   PubMedGoogle Scholar
• Sabbagh A , DarluP , Crouau-RoyB , PoloniES . Arylamine N-Acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey . PLoS ONE6 ( 4 ), e18507 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Meyer UA , ZangerUM . Molecular mechanisms of genetic polymorphisms of drug metabolism . Annu. Rev. Pharmacol. Toxicol.37 , 269 – 296 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Kiyohara C , WashioM , HoriuchiTet al. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population . Lupus18 ( 7 ), 630 – 638 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Xie HG , XuZH , OuyangDSet al. Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations . Pharmacogenetics7 ( 6 ), 503 – 514 ( 1997 ).
   PubMedGoogle Scholar
• Hou ZD , XiaoZY , GongY , ZhangYP , ZengQY . Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine . BMC Pharmacol. Toxicol.15 , 64 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ma QW , LinGF , ChenJGet al. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in Shanghai population: occupational and non-occupational bladder cancer patient groups . Biomed. Environ. Sci.17 ( 3 ), 291 – 298 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KS , BohlingSD , WittwerCT , KingTC . Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis . Nat. Med.7 ( 2 ), 249 – 253 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Huang Q , LiuZ , LiaoY , ChenX , ZhangY , LiQ . Multiplex fluorescence melting curve analysis for mutation detection with dual-labeled, self-quenched probes . PLoS ONE6 ( 4 ), e19206 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Xiong F , HuangQ , ChenXet al. A melting curve analysis – based PCR assay for one-step genotyping of beta-thalassemia mutations a multicenter validation . J. Mol. Diagn.13 ( 4 ), 427 – 435 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liao Y , ZhouY , GuoQet al. Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis . J. Clin. Microbiol.51 ( 2 ), 429 – 435 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liu R , LiuZ , XuYet al. Multicolor melting curve analysis-based multilocus melt typing of vibrio parahaemolyticus . PLoS ONE10 ( 9 ), e0136998 ( 2015 ).
   PubMed Web of Science ®Google Scholar